Pacific Biosciences of California, Inc.

PACB· NASDAQ· Health Care· Health Care Equipment & Services

$1.42+1.43%

2026-08-03

Financials

Valuation Metrics

Pacific Biosciences of California, Inc.'s Market Cap is $441M. At end of 2025 it was $565M. Ranked #2855 of 3,112 in US market (top 92%), #1257 of 1,445 on NASDAQ (top 87%), #176 of 206 in Health Care Equipment & Services (top 85%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$441M	US#2,855/3,112 Sec#176/206
Revenue	$160M	US#2,724/3,112 Sec#178/206
Net Income	$-129M	US—/3,112 Sec—/206
Total Assets	$782M	US#2,551/3,112 Sec#139/206
Net Assets	$36M	US#2,955/3,112 Sec#197/206
Value
P/B	12.22x	US#2,676/3,112 Sec#179/206
P/S	2.76x	US#1,640/3,112 Sec#115/206
FCF Yield	-26.35%	US—/3,112 Sec—/206
Profitability
ROA	-16.43%	US#2,736/3,112 Sec#170/206
Op. Margin	-101.72%	US#2,824/3,112 Sec#200/206
Revenue Growth	0.07%	US#2,230/3,112 Sec#171/206
Financial Health
Debt Ratio	2161.26%	US#2,913/3,112 Sec#198/206
Total Debt	$703M	US#1,649/3,112 Sec#91/206
FCF	$-116M	US#2,613/3,112 Sec#193/206
Cash	$56M	US#2,530/3,112 Sec#167/206
Current Ratio	5.65x	US#426/3,112 Sec#33/206
Performance
1Y Return	6.77%	US#2,000/3,112 Sec#138/206
1M Return	-15.48%	US#2,832/3,112 Sec#188/206
From 52W High	-47.99%	US#2,746/3,112 Sec#178/206
1Y MDD	-58.05%	US#2,676/3,112 Sec#168/206
Trading
Volume	3,494,635 shares	US#540/3,112 Sec#27/206
Trading Value	$5M	US#2,671/3,112 Sec#171/206
Per Share
EPS	$-1.81	US—/3,112 Sec—/206
BPS	$0.02	US#2,722/3,112 Sec#195/206